Measurable Residual Disease Monitoring of SPAG6, ST18, PRAME, and XAGE1A Expression in Peripheral Blood May Detect Imminent Relapse in Childhood Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Measurable Residual Disease Monitoring of SPAG6, ST18, PRAME, and XAGE1A Expression in Peripheral Blood May Detect Imminent Relapse in Childhood Acute Myeloid Leukemia

Published:2021-12 Issue:12 Volume:23 Page:1787-1799
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Skou Anne-Sofie^ORCID,Juul-Dam Kristian L.^ORCID,Hansen Maria,Lausen Birgitte^ORCID,Stratmann Svea^ORCID,Holmfeldt Linda^ORCID,Aggerholm Anni^ORCID,Nyvold Charlotte G.,Ommen Hans B.,Hasle Henrik

Funder

Børnecancerfonden

Karen Elise Jensens Fond

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference40 articles.

1. Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia;Pession;Blood,2013

2. Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children's Oncology Group trial AAML0531;Gamis;J Clin Oncol,2014

3. Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate;Abrahamsson;J Clin Oncol,2011

4. Gemtuzumab ozogamicin as postconsolidation therapy does not prevent relapse in children with AML: results from NOPHO-AML 2004;Hasle;Blood,2012

5. Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004;Creutzig;Blood,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting PRAME for acute myeloid leukemia therapy;Frontiers in Immunology;2024-03-26

2. SPAG6 regulates cell proliferation and apoptosis via TGF-β/Smad signal pathway in adult B-cell acute lymphoblastic leukemia;International Journal of Hematology;2023-12-26

3. Upregulated SPAG6 promotes acute myeloid leukemia progression through MYO1D that regulates the EGFR family expression;Blood Advances;2022-09-22